Schedule 13G ownership disclosure

BIOMX INC

Common Stock · CUSIP: 09090D301

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Morgan Stanley

    Shares: 1,854,032 · Class: 7.1%

  • Morgan Stanley & Co. LLC

    Shares: 1,854,032 · Class: 7.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000454
Form type
SCHEDULE 13G
Filer
BiomX Inc.
CIK
CIK 1739174
Filed
Aug 05, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub